Clinical Trial Update: JAK Inhibition in Food Allergy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a JAK inhibitor for food allergy has completed. The update summarizes early safety and pharmacology findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy

Drugs mentioned

• JAK inhibitor

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Food Allergy | Phase 1 | Status: COMPLETED